Sonja Kaubisch

Alteration of etoposide pharmacokinetics and pharmacodynamics by cyclosporine in a phase I trial to modulate multidrug resistance.

B L Lum, Sonja Kaubisch, Alan M. Yahanda et al. · Journal of Clinical Oncology · 1992 · 301 citations

Pharmacy, Pharmacokinetics, Pharmacology +15

Molecular Targets in Oncology: Implications of the Multidrug Resistance Gene

Bert L. Lum, Michael P. Gosland, Sonja Kaubisch et al. · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · 1993 · 92 citations

Medicine, Oncology, Pharmacology +12

Cost-effectiveness of prospective and continuous parenteral antibiotic control: Experience at the Palo Alto Veterans affairs medical center from 1987 to 1989

Robert W. Coleman, Lisa C. Rodondi, Sonja Kaubisch et al. · The American Journal of Medicine · 1991 · 89 citations

Pharmacy, Pharmacoeconomics, Antimicrobial Stewardship +6

Stage T1 Bladder Cancer: Grade is the Primary Determinant for Risk of Muscle Invasion

Sonja Kaubisch, Bert L. Lum, Jeffrey Reese et al. · The Journal of Urology · 1991 · 87 citations

Medicine, Oncology, Surgery +14

The use of probenecid as a chemoprotector against cisplatin nephrotoxicity

Charlotte Jacobs, Sonja Kaubisch, Joanne Halsey et al. · Cancer · 1991 · 54 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +16